Insights On Partnering

  1. Your Benefits To Working With A Clinical Research Marketing Agency 4/28/2025

    Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.

  2. 5 Questions Every Sponsor Must Ask Before Selecting An eTMF Platform 3/12/2026

    Lean teams need a strategic eTMF choice. The right platform speeds startup, cuts manual oversight, strengthens site collaboration, and keeps studies inspection‑ready as portfolios grow.

  3. An Innovative Approach To Functional Outsourcing 8/27/2025

    The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

  4. Open-Label Study Assessing Relative And Absolute Bioavailability 1/26/2026

    Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

  5. Development And Manufacture Of A Highly Potent OSD Product 10/20/2025

    Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.

  6. FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study 3/12/2026

    Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.

  7. Optimizing The Path From First-In-Human To Proof-Of-Concept 2/23/2026

    By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

  8. Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer 11/17/2025

    Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

  9. Unanticipated Roadblocks In Ovarian Cancer Drug Development 3/9/2026

    Ovarian cancer trials require specialized strategies that go beyond generic tumor designs. Enhance your program by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.

  10. Central eSource Is The Latest In Sponsor Provided Site Offerings 7/7/2025

    For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.